inSoma Bio appears in Y Combinator's company directory in the Summer 2020 batch, listed 2020-09-10. Helping Plastic Surgeons Rebuild Fat.
inSoma Bio is a Y Combinator company in the Summer 2020 batch. Its directory entry describes it as: Helping Plastic Surgeons Rebuild Fat. The founders listed are Stefan Roberts (Founder), Ashutosh Chilkoti (Founder) (Y Combinator directory entry, September 10, 2020).
Sell to companies like inSoma Bio? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New accelerator entry · 2020-09-10 · the record
Pitching, partnering or investing alongside them? See who really runs and owns inSoma Bio.
Free to see. No signup.
More on inSoma Bio and the records around it.
Same batch, Healthcare first.
Get an email when inSoma Bio changes status, grows its team or files a funding notice. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when inSoma Bio raises, hires or launches. No email unless you switch it on.
Watch inSoma Bio →Get the full cited report on inSoma Bio
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on inSoma Bio: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Checked away from the directory entry. What is below does not come from the company's Y Combinator page.
At inSoma Bio we borrow nature’s own designs to develop unique products for reconstructive plastic surgery.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
I am a professor of Biomedical Engineering at Duke University, and currently the Chair of the department. I work on genetically encoded biomaterials, drug delivery and point-of-care diagnostics. I have cofounded 5 companies — PhaseBio (NASDAQ: PHAS), Sentilus (acquired by Immucor in 2014), Gateway Bio, Isolere Bio and inSoma Bio,
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on inSoma Bio: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on inSoma Bio covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist inSoma BioYou get an alert in MentionFox the next time this company shows up.
If you're behind inSoma Bio: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry, and from the company's own site, read directly on 2026-09-27 (insomabio.com).
Each opens in a new tab, filled in for inSoma Bio. With no account yet, you sign up free and land on the result.
Share the news. Sharing needs no account.
https://mentionfox.com/funding/yc-insoma-bio